share_log

Senti Biosciences | DEF 14A: Definitive information statements

Senti Biosciences | DEF 14A: Definitive information statements

Senti Biosciences | DEF 14A：股东委托书决议
美股sec公告 ·  05/29 16:26
Moomoo AI 已提取核心信息
Senti Biosciences, Inc. (Senti) has announced the scheduling of its 2024 Annual Meeting of Stockholders to be held virtually on July 10, 2024. The meeting will be accessible online, allowing stockholders to vote electronically and submit questions. The meeting's agenda includes the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, approval of amendments to the company's Second Amended and Restated Certificate of Incorporation, and other business matters. The board has fixed May 13, 2024, as the record date for stockholders entitled to vote. Senti is utilizing the SEC's 'Notice and Access' rule to provide proxy materials online, with a Notice of Internet Availability of Proxy Materials to be mailed on or about May 29, 2024. The company emphasizes the importance of stockholder votes and encourages prompt voting ahead of the meeting.
Senti Biosciences, Inc. (Senti) has announced the scheduling of its 2024 Annual Meeting of Stockholders to be held virtually on July 10, 2024. The meeting will be accessible online, allowing stockholders to vote electronically and submit questions. The meeting's agenda includes the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, approval of amendments to the company's Second Amended and Restated Certificate of Incorporation, and other business matters. The board has fixed May 13, 2024, as the record date for stockholders entitled to vote. Senti is utilizing the SEC's 'Notice and Access' rule to provide proxy materials online, with a Notice of Internet Availability of Proxy Materials to be mailed on or about May 29, 2024. The company emphasizes the importance of stockholder votes and encourages prompt voting ahead of the meeting.
森蒂生物科学公司（Senti）宣布其2024年年度股东大会计划于2024年7月10日虚拟举行。会议将可在线访问，允许股东进行电子投票并提交问题。会议的议程包括批准毕马威会计师事务所作为截至2024年12月31日的财政年度的独立注册会计师事务所，批准对该公司第二经修订和重述的公司注册证书的修正案以及其他业务事项。董事会已将2024年5月13日定为股东有权投票的记录日期。Senti正在利用美国证券交易委员会的 “通知和访问” 规则在线提供代理材料，代理材料的互联网可用性通知将于2024年5月29日左右邮寄。该公司强调股东投票的重要性，并鼓励在会议之前迅速进行投票。
森蒂生物科学公司（Senti）宣布其2024年年度股东大会计划于2024年7月10日虚拟举行。会议将可在线访问，允许股东进行电子投票并提交问题。会议的议程包括批准毕马威会计师事务所作为截至2024年12月31日的财政年度的独立注册会计师事务所，批准对该公司第二经修订和重述的公司注册证书的修正案以及其他业务事项。董事会已将2024年5月13日定为股东有权投票的记录日期。Senti正在利用美国证券交易委员会的 “通知和访问” 规则在线提供代理材料，代理材料的互联网可用性通知将于2024年5月29日左右邮寄。该公司强调股东投票的重要性，并鼓励在会议之前迅速进行投票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息